Member Info for woodyjohn40

Hi systemzero, I’m not trying to say anything, some on here don’t get RNS alerts, so just passing it on. GL

NICE Early Value Assessment update

genedrive plc (AIM: GDR), the point of care Pharmacogenetic testing company, notes the opening of the NICE Early Value Assessment ("EVA") evidence generation funding call, supported by the National Institute for Health and Care Research (NIHR). The programme works in collaboration with the Office for Life Sciences (OLS) and the National Institute for Health and Care Excellence (NICE). The Real World Evidence Programme is backed by £10 million of government funding, as part of the UK Government's Life Sciences Vision.

The programme is aimed at addressing real world evidence gaps to accelerate widespread adoption of technologies, that have been recommended for use in the NHS through the NICE EVA framework.

Genedrive confirms that it is in the process of submitting an application for funding to address the NICE EVA evidence generation recommendations of the Genedrive® MT-RNR1 ID Kit, which are required for progressing the NICE conditional recommendation into a full recommendation.

A fair bit of buying now compared to the norm, we know what’s coming. GLA LTSHs

Ryan, read Alifs post , he does know Will Hunting, ask Alif for Wills mobile number. GL

Atisha. Another aimless Aim share,!!!

You need to find something that rhymes with MAIN MARKET.

IF you get my drift.

That’s for Ryan.

You are wrong, a couple of years ago BRH sold one of our investments and shared all the proceeds with shareholders.

For each BRH share you held you got a 40p dividend.

So I think you should read all RNA,s then maybe you will understand.

Thanks Guy, you are correct, I missed the decimal point, I meant 3.9p, but you are closer.

Have you any information on a Paraytec sale. ?

We know Paraytec is up for sale, that from the RNA on 15 December 2023, does anyone have any information to share, ie possible suitors, valuation (knowing we own %100 of it).

An update on Paraytec or Phasefocus or both would be appreciated. GLA LTSH,s

Phasefocus sale news must be close, i just hope they pay the £2.1 million proceeds as a special dividend, which would be approximately 39pence per BRH share held.

The sale of Paraytec could lead to a much higher special dividend, if and when it happens. GLA LTSH,s

26,334 Shares sold versus 35 sold. No movement of the share price, 28.5% spread. What’s happening. GLA LTSH,s

Why Woody,explain please

In 2 or 3 years we will all be reminiscing and bragging about when we bought shares in a minnow company called GST.

From our yachts or whatever floats your boat. GLA LTSH’s

Come on Qbt you’re lagging behind.

Here it goes.

Yes it came back about 30 minutes ago.

All should send emails asking for an explanation.

I’ve just mailed them again, asking why they are not communicating with the shareholders.

If they get bombarded with emails surely they will respond.

Now we need to know why it was down, an RNS must be released very soon.

GS20 EXCHANGE is back up and running.

Has anyone had a reply , I’ve just emailed them again, very disappointed in lack of communication.